Intriguing research into stock market price trends shows that investors behave strangely when a stock trades close to its 52-week high... Despite flying high, holders of the shares are more likely to sell out and snatch a profit than h...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for 1873
Return on equity (ROE) measures how efficiently a company uses Shareholders’ Equity to generate profits. For any readers unfamiliar with ROE, it is calculated by dividing net income by book value of equity. It’s no coincidence that War...
Shares in Viva Biotech Holdings (HKG:1873) are currently trading close to a 52 week high, with the share price up by around 44.8% - to 7.08 - over the past week. On a one-month basis, the Viva Biotech Holdings price has risen by 44.5%....
VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.
- Deloitte Touche Tohmatsu
Latest News for 1873
Upcoming Events for 1873
As of Today at 09:57 UTC, shares in VIVA Biotech Holdings are trading at HK$5.45. This share price information is delayed by 15 minutes.
Shares in VIVA Biotech Holdings last closed at HK$5.45 and the price had moved by -25.55% over the past 365 days. In terms of relative price strength the VIVA Biotech Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -25.27% over the past year.
The overall consensus recommendation for VIVA Biotech Holdings is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
The VIVA Biotech Holdings dividend yield is 0.19% based on the trailing twelve month period.
Last year, VIVA Biotech Holdings paid a total dividend of CNY0.01, and it currently has a trailing dividend yield of 0.19%. We do not have any data on when VIVA Biotech Holdings is to next pay dividends.
We do not have data on when VIVA Biotech Holdings is to next pay dividends. The historic dividend yield on VIVA Biotech Holdings shares is currently 0.19%.
To buy shares in VIVA Biotech Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$5.45, shares in VIVA Biotech Holdings had a market capitalisation of HK$10.49bn.
Here are the trading details for VIVA Biotech Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1873
Based on an overall assessment of its quality, value and momentum VIVA Biotech Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in VIVA Biotech Holdings is HK$9.98. That is 83.2% above the last closing price of HK$5.45.
Analysts covering VIVA Biotech Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.18 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VIVA Biotech Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -37.31%.
As of the last closing price of HK$5.45, shares in VIVA Biotech Holdings were trading -23.97% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The VIVA Biotech Holdings PE ratio based on its reported earnings over the past 12 months is 19.2. The shares last closed at HK$5.45.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on VIVA Biotech Holdings' directors